| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,244 |
1,754 |
$108K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
2,709 |
700 |
$72K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,022 |
203 |
$26K |
| 87481 |
|
745 |
547 |
$15K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,590 |
2,714 |
$7K |
| 80053 |
Comprehensive metabolic panel |
3,352 |
2,553 |
$7K |
| 87529 |
|
402 |
299 |
$5K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,064 |
777 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,170 |
1,543 |
$5K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,168 |
1,640 |
$4K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
268 |
186 |
$4K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
545 |
470 |
$4K |
| 81380 |
|
47 |
34 |
$3K |
| 87641 |
|
565 |
481 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
100 |
83 |
$3K |
| 87500 |
|
450 |
342 |
$3K |
| 81249 |
|
23 |
13 |
$2K |
| 80061 |
Lipid panel |
2,687 |
1,936 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
334 |
288 |
$2K |
| 87653 |
|
286 |
252 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
315 |
274 |
$2K |
| 81400 |
|
82 |
54 |
$2K |
| 87070 |
|
1,100 |
868 |
$2K |
| 87563 |
|
236 |
202 |
$2K |
| 82607 |
|
629 |
482 |
$2K |
| 87640 |
|
512 |
424 |
$2K |
| 84439 |
|
957 |
710 |
$1K |
| 84403 |
|
255 |
217 |
$1K |
| 86328 |
|
58 |
52 |
$1K |
| 84402 |
|
209 |
183 |
$1K |
| 86769 |
|
116 |
104 |
$1K |
| 87631 |
|
102 |
92 |
$1K |
| 84270 |
|
200 |
172 |
$1K |
| 84153 |
|
340 |
219 |
$975.18 |
| 82670 |
|
126 |
109 |
$947.01 |
| 80050 |
General health panel |
470 |
245 |
$943.46 |
| 36415 |
Collection of venous blood by venipuncture |
1,625 |
1,248 |
$929.11 |
| 87186 |
|
928 |
603 |
$885.31 |
| 87077 |
|
876 |
632 |
$878.73 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
975 |
678 |
$872.17 |
| 81001 |
|
986 |
761 |
$866.06 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
234 |
202 |
$830.24 |
| 84481 |
|
284 |
244 |
$793.50 |
| 82627 |
|
87 |
84 |
$709.16 |
| 84436 |
|
1,072 |
669 |
$647.89 |
| 82746 |
|
209 |
144 |
$635.66 |
| 82728 |
|
253 |
180 |
$631.00 |
| 87551 |
|
28 |
26 |
$586.82 |
| 81291 |
|
82 |
54 |
$549.44 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
130 |
108 |
$544.95 |
| 81240 |
|
82 |
54 |
$536.91 |
| 81241 |
|
82 |
54 |
$536.91 |
| 86696 |
|
101 |
88 |
$491.63 |
| 85652 |
|
398 |
294 |
$471.32 |
| 82533 |
|
47 |
44 |
$463.19 |
| 83001 |
|
88 |
74 |
$419.58 |
| 83002 |
|
96 |
78 |
$418.14 |
| APT16 |
|
31 |
31 |
$411.99 |
| APT17 |
|
32 |
31 |
$411.99 |
| 84702 |
|
173 |
115 |
$408.91 |
| 81226 |
|
15 |
13 |
$360.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
167 |
125 |
$328.93 |
| 83718 |
|
30 |
30 |
$309.00 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
14 |
14 |
$303.32 |
| 83735 |
|
157 |
114 |
$273.89 |
| 84144 |
|
51 |
49 |
$265.03 |
| 84479 |
|
830 |
464 |
$231.64 |
| 83550 |
|
169 |
111 |
$231.43 |
| 82043 |
|
231 |
165 |
$222.82 |
| 83540 |
|
187 |
127 |
$219.83 |
| 86592 |
|
184 |
154 |
$218.43 |
| 87581 |
|
102 |
92 |
$182.88 |
| 87625 |
|
37 |
33 |
$180.34 |
| 82172 |
|
26 |
16 |
$135.24 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
35 |
31 |
$90.96 |
| 87340 |
|
34 |
28 |
$89.62 |
| 82040 |
|
252 |
214 |
$87.12 |
| 84146 |
|
28 |
25 |
$73.11 |
| 86141 |
|
24 |
15 |
$65.40 |
| 80076 |
|
19 |
19 |
$64.24 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
40 |
28 |
$61.16 |
| 87102 |
|
71 |
56 |
$60.24 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
34 |
19 |
$53.44 |
| 83090 |
|
26 |
16 |
$42.79 |
| 82570 |
|
18 |
15 |
$41.36 |
| 86762 |
|
18 |
13 |
$35.12 |
| 87205 |
|
44 |
40 |
$34.12 |
| 87106 |
|
20 |
17 |
$25.24 |
| 80164 |
|
12 |
12 |
$20.42 |
| 85610 |
|
17 |
12 |
$14.84 |
| 87206 |
|
12 |
12 |
$9.09 |
| 84550 |
|
82 |
71 |
$6.25 |
| P9603 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled |
14 |
12 |
$0.79 |
| 81223 |
|
23 |
13 |
$0.00 |
| 81373 |
|
31 |
13 |
$0.00 |
| 82248 |
|
13 |
13 |
$0.00 |